New insight into device therapy for chronic heart failure
Ypenburg, C.
Citation
Ypenburg, C. (2008, October 30). New insight into device therapy for chronic heart failure. Retrieved from https://hdl.handle.net/1887/13210
Version: Corrected Publisher’s Version
License: Licence agreement concerning inclusion of doctoral thesis in the Institutional Repository of the University of Leiden
Downloaded from: https://hdl.handle.net/1887/13210
Note: To cite this publication please use the final published version (if
applicable).
New insights into device therapy for chronic heart failure
Claudia Ypenburg
The studies described in this thesis were performed at the department of Cardiology of the Leiden University Medical Center, Leiden, the Netherlands
Copyright © 2008 Claudia Ypenburg, Leiden, the Netherlands. All rights reserved. No part of this book may be reproduced or transmitted in any form or by any means, without prior written permission of the author
Lay out: Chris Bor, Amsterdam, the Netherlands
Printed by: Buijten & Schipperheijn, Amsterdam, the Netherlands ISBN: 978-90-9023388-8
Financial support to the costs associated with the publication of this thesis from Biotronik BV, Boehringer Ingelheim BV, Boston Scientific BV, Bristol-Meyers Squibb BV, Eli Lilly BV, GE Healthcare Medical Diagnostics, de J.E. Jurriaanse stichting, Medtronic BV, Merck Sharp &
Dohme BV, Novartis-Pharma BV, Pfizer BV, Sanofi-Aventis BV, Schering-Plough BV, Stichting EMEX, St. Jude Medical NL BV, Toshiba Medical Systems BV and Zambon NL BV is gratefully acknowledged.
New insights into device therapy for chronic heart failure
PROEFSCHRIFT
ter verkrijging van
de graad van Doctor aan de Universiteit van Leiden, op gezag van Rector Magnificus prof. mr. P.F. van der Heijden,
volgens besluit van het College voor Promoties te verdedigen op donderdag 30 oktober 2008
klokke 15.00 uur
door
CLAUDIA YPENBURG
geboren te Amstelveen1979
PROMOTIECOMISSIE
Promotores: Prof. dr. J.J. Bax Prof. dr. M.J. Schalij
Referent: Prof. dr. J. Brugada (Hopital Clinic, Barcelona, Spanje)
Overige leden: Prof. dr. E.E. van der Wall Prof. dr. R.J. Klautz
Prof. dr. H.J. Wellens (Academisch Ziekenhuis Maastricht) Mw. dr. L. van Erven
Financial support by the Netherlands Heart Foundation and the Interuniversity Cardiology Institute of the Netherlands for the publication of this thesis is gratefully acknowledged.
Voor David en Finn
TABLE OF CONTENTS
Chapter 1 General introduction and outline of the thesis 9
PART I ISSUES BEFORE DEVICE IMPLANTATION
21Chapter 2 Assessment of left ventricular dyssynchrony by speckle tracking strain imaging: comparison between longitudinal, circumferential and radial strain in cardiac resynchronization therapy patients
J Am Coll Cardiol 2008;51:1944-52
23
Chapter 3 Left ventricular resynchronization is mandatory for response to cardiac resynchronization therapy: analysis in patients with evidence of left ventricular dyssynchrony at baseline
Circulation 2007;116:1440-8
39
Chapter 4 Extent of viability to predict response to cardiac resynchronization therapy in ischemic heart failure patients
J Nucl Med 2006;47:1565-70
51
Chapter 5 Impact of viability and scar tissue on response to cardiac resynchronization therapy in ischemic heart failure patients
Eur Heart J 2006;28:33-41
63
Chapter 6 Effect of total scar burden on contrast-enhanced magnetic resonance imaging on response to cardiac resynchronization therapy
Am J Cardiol 2007;99:657-60
79
Chapter 7 Myocardial contractile reserve predicts improvement in left ventricular function after cardiac resynchronization therapy
Am Heart J 2007;154:1160-5
89
Chapter 8 Optimal left ventricular lead position predicts reverse remodeling and survival after cardiac resynchronization therapy
J Am Coll Cardiol 2008; in press
101
Chapter 9 Non-invasive imaging in cardiac resynchronization therapy – part 1:
selection of patients PACE 2008; in press
115
PART II ISSUES AFTER DEVICE IMPLANTATION
151Chapter 10 Long-term prognosis after cardiac resynchronization therapy is related to the extent of left ventricular reverse remodeling at mid-term follow-up Submitted
153
Chapter 11 Effects of interruption of long-term cardiac resynchronization therapy on left ventricular function and dyssynchrony
Am J Cardiol 2008; in press
167
Chapter 12 Changes in global left ventricular function in heart failure patients undergoing cardiac resynchronization therapy using novel automated function imaging
Submitted
177
Chapter 13 Acute effects of initiation and withdrawal of cardiac resynchronization therapy on papillary muscle dyssynchrony and mitral regurgitation J Am Coll Cardiol 2007;50:2071-7
191
Chapter 14 Mechanism of improvement in mitral regurgitation after cardiac resynchronization therapy
Eur Heart J 2008;29:757-65
205
Chapter 15 Benefit of combined resynchronization and defibrillator therapy in heart failure patients with and without ventricular arrhythmias
J Am Coll Cardiol 2006;48:464-70
221
Chapter 16 Intrathoracic impedance monitoring to predict decompensated heart failure
Am J Cardiol 2006;99:554-7
235
Chapter 17 Non-invasive imaging in cardiac resynchronization therapy – part 2:
follow-up and optimization of settings PACE 2008; in press
243
Summary, conclusions and future perspectives 265
Samenvatting, conclusies en toekomstperspectief 275
List of publications 283
Acknowledgements 287
Curiculum vitae 288
